QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings
- Conditions
- Tobacco Use
- Interventions
- Behavioral: QA-DDS
- Registration Number
- NCT02570646
- Lead Sponsor
- Jamie Studts
- Brief Summary
Using a single-arm trial design, this study will examine the feasibility and acceptability of evaluating QuitAdvisorDDS, a clinical decision support software application designed to facilitate implementation of evidence-based tobacco treatment interventions into the dental setting. The study will examine the feasibility and acceptability of evaluating the impact of the QuitAdvisorDDS tool on patient outcomes related to tobacco use and cessation attempts as well as provider knowledge, attitudes, and practices regarding tobacco treatment. Practitioners (dentists and hygienists) will complete surveys at baseline and follow-up, while patients will complete surveys at baseline and 1-month follow-up. An embedded substudy will also evaluate the feasibility and acceptability of collecting biospecimens (saliva) to serve as biochemical verification of smoking status.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 248
- Receives dental care from a participating practitioner;
- Is age 18 or older;
- Self-reports tobacco use within the past month;
- Willing to comply with all study procedures and be available for the duration of the study;
- Willing to provide verbal informed consent;
- Has access to a telephone, and agrees to receive text messages, emails, or telephone calls related to the study. (The patient's preferred method of contact will be ascertained).
- Willing to be contacted on a regular basis by each of these entities: the practice;Regional Coordinators (RC) and/or University of Kentucky (UK) researchers; and
- Willing to provide contact information of one person living at a different address who will know the patient's whereabouts in the event the patient cannot be reached.
- Psychiatric disability or mental illness judged by the practitioner to be clinically significant so as to preclude informed consent or compliance with procedures of study visits.
- Cognitive impairment judged by the practitioner to be significant so as to preclude informed consent or compliance with procedures of study visits.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description QA-DDS QA-DDS Patients will receive exposure to the QA-DDS tool from their dental care practitioner.
- Primary Outcome Measures
Name Time Method Primary Patient Feasibility A: Rate of Patient Completion of 1-Month Follow-Up Survey 1-Month Follow-Up 80% of the enrolled dental care patients must complete the 1-month follow-up survey with the 7-day point prevalence measure of self-reported smoking status.
Primary Patient Acceptability A: Rate of Patient Wanting Provider to Use QA-DDS Immediately Post-Consultation up to 1 week 80% of participating patients must indicate that they would want their dental practitioner to continue to use QA-DDS.
Primary Patient Acceptability B: Rate of Patient Wanting to Use QA-DDS Patient Portal 1-Month Follow-Up 80% of participating patients must indicate that they would want to continue to use the QA-DDS Patient Portal.
- Secondary Outcome Measures
Name Time Method Secondary Patient Acceptability A: Average QA-DDS Satisfaction Ratings Among Patients on 0-10 Scale Immediately Post-Consultation up to 1 week Average QA-DDS satisfaction ratings among enrolled dental patients must be 7 or greater on a 0-10 scale.
Secondary Patient Feasibility A: Rate of Patient Accrual by Study Practices 4-Month Follow-Up 75% of the study practices must recruit 10 eligible dental patients within a 4-month recruitment phase
Trial Locations
- Locations (1)
University of Kentucky
🇺🇸Lexington, Kentucky, United States